Saturday 17 October 2026
Export NHTC’s income statement to Excel — free account
Natural Health Trends Corp.
NHTC Consumer Cyclical Internet Retail
Natural Health Trends Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.8 million, down 7.42% from fiscal 2024. In the quarter to June 2026, revenue fell 22.5%, EPS fell 3,946.2% and free cash flow grew 70.1%, each against the same quarter a year earlier.
0.97
0.01
+1.04%
Follow NHTC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.42 | 0.74 | 0.89 | 1.26 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(11.13) | (35.51) | (37.04) | 454.91 | |
P/B ratio |
1.00 | 1.72 | 1.52 | 1.97 | |
Price to Tangible BV |
1.13 | 1.93 | 1.64 | 2.11 | |
EV/Sales |
(0.10) | 0.18 | 0.17 | 0.47 | |
EV/EBITDA |
1.59 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
1.14 | (0.97) | (1.11) | (3.92) | |
EV/FCF |
0.98 | (0.95) | (1.10) | (3.85) | |
Quick Ratio |
1.56 | 1.60 | 2.11 | 2.17 | |
Current Ratio |
1.99 | 2.00 | 2.50 | 2.57 | |
Net Debt/EBITDA |
30.04 | 45.86 | 47.10 | 68.54 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.97 | 0.90 | 0.85 | 0.81 | |
Operating CF/Net income |
3.02 | 5.18 | 1.63 | (0.26) | |
Capex/Depreciation |
(14.13) | (10.45) | (0.23) | (1.54) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
42.79% | 38.28% | 39.13% | 38.05% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.30% | 0.37% | |
Graham Net Nets |
0.64 | 0.39 | 0.54 | 0.42 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(8.77%) | (3.72%) | (2.55%) | (0.30%) | |
Free Cash Flow Yield |
(23.02%) | (26.31%) | (17.07%) | (9.79%) | |
Revenue per Share |
0.89 | 0.91 | 0.85 | 0.82 | |
Operating CF per Share |
(0.16) | (0.08) | (0.08) | 0.01 | |
Capex per Share |
(0.04) | (0.01) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.20) | (0.09) | (0.08) | 0.01 | |
Cash per Share |
2.17 | 2.09 | 2.51 | 2.78 | |
Shareholders Equity per Share |
1.77 | 1.62 | 2.04 | 2.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.77 | 1.62 | 2.04 | 2.27 | |
Free Cash Flow |
(1.69) | (0.91) | (0.96) | 0.07 | |
Working Capital |
11.77 | 13.29 | 20.51 | 23.13 | |
Capital Expenditures |
(0.32) | (0.11) | 0.00 | (0.04) | |
Net Current Asset Value |
9.70 | 11.05 | 19.20 | 21.79 | |
EV/EBIT |
1.53 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.01 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
0.96 | 1.14 | 0.73 | 0.78 | |
Average Inventory |
2.41 | 2.39 | 2.66 | 2.92 | |
Average Assets |
37.19 | 42.56 | 46.89 | 50.27 | |
Average Common Equity |
22.03 | 23.67 | 28.15 | 30.73 |
Columns are period end dates